An emerging role of glucagon-like peptide-1 in preventing advanced-glycation-end-product-mediated damages in diabetes
about
IL-1β, RAGE and FABP4: targeting the dynamic trio in metabolic inflammation and related pathologies.Retinal pigment epithelial cells express a functional receptor for glucagon-like peptide-1 (GLP-1).Crosstalk between advanced glycation end products (AGEs)-receptor RAGE axis and dipeptidyl peptidase-4-incretin system in diabetic vascular complications.Glycation in Parkinson's disease and Alzheimer's disease.Pioglitazone and exenatide enhance cognition and downregulate hippocampal beta amyloid oligomer and microglia expression in insulin-resistant rats.Effects of Glucagon-Like Peptide-1 on Oxidative Stress and Nrf2 Signaling.
P2860
An emerging role of glucagon-like peptide-1 in preventing advanced-glycation-end-product-mediated damages in diabetes
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
An emerging role of glucagon-l ...... t-mediated damages in diabetes
@ast
An emerging role of glucagon-l ...... t-mediated damages in diabetes
@en
type
label
An emerging role of glucagon-l ...... t-mediated damages in diabetes
@ast
An emerging role of glucagon-l ...... t-mediated damages in diabetes
@en
prefLabel
An emerging role of glucagon-l ...... t-mediated damages in diabetes
@ast
An emerging role of glucagon-l ...... t-mediated damages in diabetes
@en
P2860
P50
P356
P1476
An emerging role of glucagon-l ...... t-mediated damages in diabetes
@en
P2093
Alessio Nencioni
François Mach
P2860
P304
P356
10.1155/2013/591056
P577
2013-01-10T00:00:00Z